New Director of AIDS Research

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 7
Volume 7
Issue 7

BETHESDA, Md--NIH director Harold Varmus, MD, has named Neal Nathanson, MD, to serve as the new director of NIH’s Office of AIDS Research (OAR). Dr. Nathanson, a leader in viral pathogenesis, comes to the NIH from the University of Pennsylvania Medical Center, where he was Vice Dean for Research and Research Training. He is an active member of the NIH AIDS Vaccine Research Committee, chaired by Dr. David Baltimore.

BETHESDA, Md--NIH director Harold Varmus, MD, has named Neal Nathanson, MD, to serve as the new director of NIH’s Office of AIDS Research (OAR). Dr. Nathanson, a leader in viral pathogenesis, comes to the NIH from the University of Pennsylvania Medical Center, where he was Vice Dean for Research and Research Training. He is an active member of the NIH AIDS Vaccine Research Committee, chaired by Dr. David Baltimore.

Recent Videos
Ronald Bleday, MD, stated that before standardizing a stepwise approach to treating surgical pain, providers might have overtreated patients with opioids.
1 expert is featured in this series.
2 experts are featured in this series.
2 experts are featured in this series.
A third of patients had a response [to lifileucel], and of the patients who have a response, half of them were alive at the 4-year follow-up.
1 expert is featured in this series.
Conducting trials safely within a community setting lies at the heart of a successful collaboration between Northwell Health and START.
We are seeing that, in those patients who have relapsed/refractory melanoma with survival measured as a few weeks and no effective treatments, about a third of these patients will have a response.
We have the current CAR [T-cell therapies], which target CD19; however, we need others.
Related Content